India Pharma Outlook’s Manufacturers & Consultants Special - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board.
We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products. - Beta Drugs
DIGSS India has incorporated sustainability and energy optimization into its engineering philosophy through intelligent system design and lifecycle-focused planning - DIGSS India
A key strength of Medkem lies in its vertically integrated service model, which spans APIs, intermediates, and finished formulations - Medkem Laboratories
As nephrology enters an era increasingly influenced by biologics, precision medicine, pharmacogenomics, digital health, and interventional therapies, RPG Life Sciences is positioning itself for the next phase of renal innovation - RPG Life Sciences
Our focus is to combine clinical science with advanced delivery technologies that improve nutrient absorption, supported by collaborations with globally renowned medical professionals, scientists, and formulation experts - Vitoonnix
Our subscribers play a decisive role in finalization of our annual list of Manufacturers & Consultants Special - 2026 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
 |  | Beta Drugs | For a country adding 1400,000 new cancer cases every year, the scale of the crisis alone is staggering. Yet in India, where nearly 40 percent of cancer hospitalizations are financed through borrowings, asset sales, or support from relatives, the economics of survival have long been as brutal as the disease itself. |
 |  | Digss India | According to industry estimates, India’s pharmaceutical market is expected to continue its strong growth trajectory, supported by rising investments in biologics, sterile manufacturing, contract development and manufacturing (CDMO) services, and exports to regulated markets. |
 |  | Medkem Laboratories | In the evolving landscape of global healthcare, the role of a Contract Manufacturing Organization (CMO) has expanded far beyond production. Today, CMOs are stra-tegic partners that bridge the gap between innovation and accessibility, enabling pharmaceutical companies to scale efficiently while maintaining stringent quality standards. |
 |  | RPG Life Sciences | Kidney disease has become one of the defining healthcare challenges of the twenty-first century. What was once regarded primarily as a consequence of diabetes or hypertension has evolved into a complex, lifelong condition requiring coordinated management across prevention, transplantation, dialysis, pharmacotherapy, and long-term monitoring. |
 |  | Vitonnix | The global nutraceutical industry is undergoing a profound transformation. As consumers become increasingly health-conscious and preventive healthcare gains prominence, attention is shifting beyond nutritional ingredients to a more fundamental question: how effectively are those nutrients being absorbed and utilised by the body |
